Yoon SY - Search Results

1

A phase II trial of pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), a novel anti-fibrosing agent, in myelofibrosis with myeloid metaplasia.

Mesa RA, Tefferi A, Elliott MA, Hoagland HC, Call TG, Schroeder GS, Yoon SY, Li CY, Gray LA, Margolin S, Hook CC. Mesa RA, et al. Among authors: yoon sy. Br J Haematol. 2001 Jul;114(1):111-3. doi: 10.1046/j.1365-2141.2001.02883.x. Br J Haematol. 2001. PMID: 11472354 Free article. Clinical Trial.

2

Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia.

Elliot MA, Yoon SY, Kao P, Li CY, Tefferi A. Elliot MA, et al. Among authors: yoon sy. Eur J Haematol. 2002 Mar;68(3):175-9. doi: 10.1034/j.1600-0609.2002.01534.x. Eur J Haematol. 2002. PMID: 12068799

3

Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

Yoon SY, Li CY, Mesa RA, Tefferi A. Yoon SY, et al. Br J Haematol. 1999 Sep;106(3):682-8. doi: 10.1046/j.1365-2141.1999.01598.x. Br J Haematol. 1999. PMID: 10468856 Free article.

4

Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders.

Yoon SY, Li CY, Lloyd RV, Tefferi A. Yoon SY, et al. Int J Hematol. 2000 Oct;72(3):337-42. Int J Hematol. 2000. PMID: 11185990

5

Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia.

Mesa RA, Hanson CA, Li CY, Yoon SY, Rajkumar SV, Schroeder G, Tefferi A. Mesa RA, et al. Among authors: yoon sy. Blood. 2002 Jun 1;99(11):4131-7. doi: 10.1182/blood.v99.11.4131. Blood. 2002. PMID: 12010817 Free article.

6

Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis.

Tefferi A, Yoon SY, Li CY. Tefferi A, et al. Among authors: yoon sy. Blood. 2000 Jul 15;96(2):771-2. Blood. 2000. PMID: 10887148 Free article.

7

Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders.

Yoon SY, Tefferi A, Li CY. Yoon SY, et al. Haematologica. 2001 Jan;86(1):52-7. Haematologica. 2001. PMID: 11146571

8

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.

Tefferi A, Elliot MA, Yoon SY, Li CY, Mesa RA, Call TG, Dispenzieri A. Tefferi A, et al. Among authors: yoon sy. Blood. 2001 Mar 15;97(6):1896. doi: 10.1182/blood.v97.6.1896. Blood. 2001. PMID: 11263440 Free article. Clinical Trial. No abstract available.

9

Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow.

Yoon SY, Tefferi A, Li CY. Yoon SY, et al. Acta Haematol. 2000;104(4):151-7. doi: 10.1159/000046507. Acta Haematol. 2000. PMID: 11279303

10

Hydroxyurea-induced marked oscillations of platelet counts in patients with polycythemia vera.

Tefferi A, Elliott MA, Kao PC, Yoon S, El-Hemaidi I, Pearson TC. Tefferi A, et al. Blood. 2000 Aug 15;96(4):1582-4. Blood. 2000. PMID: 10942409 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,090 results

Search Page

Filters